Literature DB >> 17053984

Simulation of correlated continuous and categorical variables using a single multivariate distribution.

Stacey J Tannenbaum1, Nicholas H G Holford, Howard Lee, Carl C Peck, Diane R Mould.   

Abstract

Clinical trial simulations make use of input/output models with covariate effects; the virtual patient population generated for the simulation should therefore display physiologically reasonable covariate distributions. Covariate distribution modeling is one method used to create sets of covariate values (vectors) that characterize individual virtual patients, which should be representative of real subjects participating in clinical trials. Covariates can be continuous (e.g., body weight, age) or categorical (e.g., sex, race). A modeling method commonly used for incorporating both continuous and categorical covariates, the Discrete method, requires the patient population to be divided into subgroups for each unique combination of categorical covariates, with separate multivariate functions for the continuous covariates in each subset. However, when there are multiple categorical covariates this approach can result in subgroups with very few representative patients, and thus, insufficient data to build a model that characterizes these patient groups. To resolve this limitation, an application of a statistical methodology (Continuous method) was conceived to enable sampling of complete covariate vectors, including both continuous and categorical covariates, from a single multivariate function. The Discrete and Continuous methods were compared using both simulated and real data with respect to their ability to generate virtual patient distributions that match a target population. The simulated data sets consisted of one categorical and two correlated continuous covariates. The proportion of patients in each subgroup, correlation between the continuous covariates, and ratio of the means of the continuous covariates in the subgroups were varied. During evaluation, both methods accurately generated the summary statistics and proper proportions of the target population. In general, the Continuous method performed as well as the Discrete method, except when the subgroups, defined by categorical value, had markedly different continuous covariate means, for which, in the authors' experience, there are few clinically relevant examples. The Continuous method allows analysis of the full population instead of multiple subgroups, reducing the number of analyses that must be performed, and thereby increasing efficiency. More importantly, analyzing a larger pool of data increases the precision of the covariance estimates of the covariates, thus improving the accuracy of the description of the covariate distribution in the simulated population.

Entities:  

Mesh:

Year:  2006        PMID: 17053984     DOI: 10.1007/s10928-006-9033-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  8 in total

1.  Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study.

Authors:  K G Kowalski; M M Hutmacher
Journal:  Stat Med       Date:  2001-01-15       Impact factor: 2.373

Review 2.  Simulation of clinical trials.

Authors:  N H Holford; H C Kimko; J P Monteleone; C C Peck
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 3.  Clinical trial simulation in drug development.

Authors:  P L Bonate
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

4.  Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization.

Authors:  C Veyrat-Follet; R Bruno; R Olivares; G R Rhodes; P Chaikin
Journal:  Clin Pharmacol Ther       Date:  2000-12       Impact factor: 6.875

5.  Development of a predictive pharmacokinetic model for a novel cyclooxygenase-2 inhibitor.

Authors:  H Kastrissios; S Rohatagi; J Moberly; K Truitt; Y Gao; R Wada; M Takahashi; K Kawabata; D Salazar
Journal:  J Clin Pharmacol       Date:  2006-05       Impact factor: 3.126

6.  Enriched analgesic efficacy studies: an assessment by clinical trial simulation.

Authors:  Hendrikus J M Lemmens; D Russell Wada; Catherine Munera; Ahmed Eltahtawy; Donald R Stanski
Journal:  Contemp Clin Trials       Date:  2005-11-28       Impact factor: 2.226

Review 7.  Smoking-induced elevations in blood carboxyhaemoglobin levels. Effect on maximal oxygen uptake.

Authors:  P McDonough; R J Moffatt
Journal:  Sports Med       Date:  1999-05       Impact factor: 11.136

8.  Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris.

Authors:  Sylvie Chabaud; Pascal Girard; Patrice Nony; Jean-Pierre Boissel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

  8 in total
  8 in total

1.  Performance of methods for handling missing categorical covariate data in population pharmacokinetic analyses.

Authors:  Ron J Keizer; Anthe S Zandvliet; Jos H Beijnen; Jan H M Schellens; Alwin D R Huitema
Journal:  AAPS J       Date:  2012-05-31       Impact factor: 4.009

2.  A Novel Approach to Generate a Virtual Population of Human Coronary Arteries for In Silico Clinical Trials of Stent Design.

Authors:  Dimitrios Pleouras; Antonis Sakellarios; George Rigas; Georgia S Karanasiou; Panagiota Tsompou; Gianna Karanasiou; Vassiliki Kigka; Savvas Kyriakidis; Vasileios Pezoulas; George Gois; Nikolaos Tachos; Aidonis Ramos; Gualtiero Pelosi; Silvia Rocchiccioli; Lampros Michalis; Dimitrios I Fotiadis
Journal:  IEEE Open J Eng Med Biol       Date:  2021-05-20

3.  Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients.

Authors:  Hesham Al-Sallami; Fiona Newall; Paul Monagle; Vera Ignjatovic; Noel Cranswick; Stephen Duffull
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

4.  Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques.

Authors:  D Teutonico; F Musuamba; H J Maas; A Facius; S Yang; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2015-05-21       Impact factor: 4.200

5.  Application of two machine learning algorithms to genetic association studies in the presence of covariates.

Authors:  Bareng A S Nonyane; Andrea S Foulkes
Journal:  BMC Genet       Date:  2008-11-14       Impact factor: 2.797

6.  The impact of missing data on analyses of a time-dependent exposure in a longitudinal cohort: a simulation study.

Authors:  Amalia Karahalios; Laura Baglietto; Katherine J Lee; Dallas R English; John B Carlin; Julie A Simpson
Journal:  Emerg Themes Epidemiol       Date:  2013-08-19

7.  Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques.

Authors:  Giovanni Smania; E Niclas Jonsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-04

8.  Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning.

Authors:  Matej Pičulin; Tim Smole; Bojan Žunkovič; Enja Kokalj; Marko Robnik-Šikonja; Matjaž Kukar; Dimitrios I Fotiadis; Vasileios C Pezoulas; Nikolaos S Tachos; Fausto Barlocco; Francesco Mazzarotto; Dejana Popović; Lars S Maier; Lazar Velicki; Iacopo Olivotto; Guy A MacGowan; Djordje G Jakovljević; Nenad Filipović; Zoran Bosnić
Journal:  JMIR Med Inform       Date:  2022-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.